Clearlake Capital Group has completed fundraising for Clearlake Capital Partners V (Fund V) with over USD3.6 billion in commitments. Fund V exceeded its target and was substantially oversubscribed, reaching its hard cap. At over USD3.6 billion, Fund V is Clearlake’s largest private equity fund to date. This brings Clearlake’s total cumulative capital

Tikehau Capital, a pan-European alternative asset management and investment company, and SPRIM Ventures, a medical and scientific consultancy firm, has held the initial closing of their first venture capital fund, TKS1, which will focus on early stage investments in med-tech and life science companies. Total committed capital for the fund

PineBridge Investments, has closed its latest secondary fund, PineBridge Secondary Partners IV (PSP IV), with total capital commitments of USD568 million, above an initial target of USD500 million. PSP IV attracted a global investor base, represented by a wide range of limited partners from the Americas, Asia, Europe and the

The Greater Manchester Combined Authority has launched a new loan fund to promote the production and distribution of energy derived from renewable resources in the region. The GBP15 million Greater Manchester Low Carbon Fund has been allocated from the 2014-2020 European Regional Development Fund and has a lifespan of 15

Albion Capital has closed its 2017/2018 VCT top up offers after successfully raising the GBP32 million targeted amount. The offers, which launched on 6 September 2017, are fully subscribed across the five Albion VCTs participating in the fundraising. 

 Albion Capital will now focus on investing the money raised in

Station 12 Asset Management, a specialist venture capital investor in media, entertainment and knowledge, is to raise GBP60m in two funds – one aimed at institutional investors and the other at the private EIS/SEIS sector. Station 12, which was founded just over three years ago, has already built a successful track

New State Capital Partners has closed its second institutional investment fund, New State Capital Partners Fund II, with USD255 million in committed capital. The Fund exceeded its target and closed at its hard cap and New State now has in excess of USD800 million AUM as a result. New State

BioMedPartners AG, based in Basel, Switzerland, has held the final closing of BioMedInvest III, the company’s third equity venture capital fund, at CHF100 million. BioMedInvest III is a healthcare venture capital fund which invests in private early-to-mid- stage companies in Switzerland, Germany and neighbouring countries of the European Union.  

Boutique asset manager Unigestion has held the final close of Unigestion Secondary Opportunity IV (USO IV), the firm’s fourth global small and mid-market private equity secondary investment program, at EUR306 million – nearly twice the size of its predecessor fund. USO IV has already completed 11 secondary transactions across North

SwanCap has held the final close for its latest fund at EUR433 million, comfortably exceeding its EUR400 million target. SWAN III provides exposure to the private equity mid-market in Europe and North America via a combination of primary funds, direct co- investments as well as select secondaries.   The LP